NCT06590285 Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
| NCT ID | NCT06590285 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Scripps Health |
| Condition | GVHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-02 |
| Primary Completion | 2031-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-02 with a primary completion date of 2031-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.
Eligibility Criteria
Inclusion Criteria: * Male or female patients aged 18 or older at the time of study informed consent. * Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible. * Patients have access to digital device capable of downloading study app * Patients able to read study documents and able to complete informed consent within the study app Exclusion Criteria: * Failed prior alloHSCT within the past 6 months
Contact & Investigator
Jake New, MD, PhD
PRINCIPAL INVESTIGATOR
Scripps Clinic
Frequently Asked Questions
Who can join the NCT06590285 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying GVHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06590285 currently recruiting?
Yes, NCT06590285 is actively recruiting participants. Contact the research team at new.jacob@scrippshealth.org for enrollment information.
Where is the NCT06590285 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT06590285 clinical trial?
NCT06590285 is sponsored by Scripps Health. The principal investigator is Jake New, MD, PhD at Scripps Clinic. The trial plans to enroll 60 participants.